Table of Contents
Fetching ...

Unlocking Biomedical Insights: Hierarchical Attention Networks for High-Dimensional Data Interpretation

Rekha R Nair, Tina Babu, Alavikunhu Panthakkan, Hussain Al-Ahmad, Balamurugan Balusamy

TL;DR

This work tackles the challenge of achieving high predictive accuracy for high-dimensional biomedical data while maintaining interpretability, a critical requirement for clinical deployment. It introduces the Hierarchical Attention-based Interpretable Network (HAIN), which fuses multi-level attention, dimensionality reduction, and explanation-driven losses to provide both local and global interpretability alongside strong classification performance. On The Cancer Genome Atlas (TCGA), HAIN achieves an accuracy of 94.3% (AUC-ROC 0.987) and delivers faithful, rapid explanations that align with known cancer biomarkers and pathways, surpassing post-hoc methods like SHAP and LIME. The approach enables robust biomarker discovery and supports precision medicine with transparent AI that is scalable through distributed training and memory-efficient attention.

Abstract

The proliferation of high-dimensional datasets in fields such as genomics, healthcare, and finance has created an urgent need for machine learning models that are both highly accurate and inherently interpretable. While traditional deep learning approaches deliver strong predictive performance, their lack of transparency often impedes their deployment in critical, decision-sensitive applications. In this work, we introduce the Hierarchical Attention-based Interpretable Network (HAIN), a novel architecture that unifies multi-level attention mechanisms, dimensionality reduction, and explanation-driven loss functions to deliver interpretable and robust analysis of complex biomedical data. HAIN provides feature-level interpretability via gradientweighted attention and offers global model explanations through prototype-based representations. Comprehensive evaluation on The Cancer Genome Atlas (TCGA) dataset demonstrates that HAIN achieves a classification accuracy of 94.3%, surpassing conventional post-hoc interpretability approaches such as SHAP and LIME in both transparency and explanatory power. Furthermore, HAIN effectively identifies biologically relevant cancer biomarkers, supporting its utility for clinical and research applications. By harmonizing predictive accuracy with interpretability, HAIN advances the development of transparent AI solutions for precision medicine and regulatory compliance.

Unlocking Biomedical Insights: Hierarchical Attention Networks for High-Dimensional Data Interpretation

TL;DR

This work tackles the challenge of achieving high predictive accuracy for high-dimensional biomedical data while maintaining interpretability, a critical requirement for clinical deployment. It introduces the Hierarchical Attention-based Interpretable Network (HAIN), which fuses multi-level attention, dimensionality reduction, and explanation-driven losses to provide both local and global interpretability alongside strong classification performance. On The Cancer Genome Atlas (TCGA), HAIN achieves an accuracy of 94.3% (AUC-ROC 0.987) and delivers faithful, rapid explanations that align with known cancer biomarkers and pathways, surpassing post-hoc methods like SHAP and LIME. The approach enables robust biomarker discovery and supports precision medicine with transparent AI that is scalable through distributed training and memory-efficient attention.

Abstract

The proliferation of high-dimensional datasets in fields such as genomics, healthcare, and finance has created an urgent need for machine learning models that are both highly accurate and inherently interpretable. While traditional deep learning approaches deliver strong predictive performance, their lack of transparency often impedes their deployment in critical, decision-sensitive applications. In this work, we introduce the Hierarchical Attention-based Interpretable Network (HAIN), a novel architecture that unifies multi-level attention mechanisms, dimensionality reduction, and explanation-driven loss functions to deliver interpretable and robust analysis of complex biomedical data. HAIN provides feature-level interpretability via gradientweighted attention and offers global model explanations through prototype-based representations. Comprehensive evaluation on The Cancer Genome Atlas (TCGA) dataset demonstrates that HAIN achieves a classification accuracy of 94.3%, surpassing conventional post-hoc interpretability approaches such as SHAP and LIME in both transparency and explanatory power. Furthermore, HAIN effectively identifies biologically relevant cancer biomarkers, supporting its utility for clinical and research applications. By harmonizing predictive accuracy with interpretability, HAIN advances the development of transparent AI solutions for precision medicine and regulatory compliance.
Paper Structure (27 sections, 10 equations, 5 figures, 3 tables, 3 algorithms)

This paper contains 27 sections, 10 equations, 5 figures, 3 tables, 3 algorithms.

Figures (5)

  • Figure 1: ROC Curves by Cancer Type
  • Figure 2: Training Loss Convergence
  • Figure 3: Attention Weight Distribution Analysis
  • Figure 4: Interactive Attention Weight Plot
  • Figure 5: Attention Weight vs Literature Support